Skip over navigation
Directory
Directory Search
Jobs
Job Search
Post a Job
Patient
Patient Resources
Drug Development
History
Genealogy
Toons & Teasers
About
Advertising
Home
Quick Links
Directory
Job Search
Toons & Teasers
Advertising
LifeScienceHistory.com - Check us out on Instagram
Industry News
Search Articles:
Opdivo (nivolumab) plus low-dose Yervoy (ipilimumab) demonstrates durable clinical benefit
Bristol-Myers Squibb announced new data from a cohort of the CheckMate -142 study in which Opdivo (nivolumab) plus low-dose Yervoy (ipilimumab) demonstrated durable clinical benefit as a first-line treatment in patients with MSI-H or dMMR mCRC.
October 22, 2018
More...
Email This Page
to a Friend
Print This
Page